Derminol Cream is used to prevent the symptoms of asthma. It is also used to prevent and treat a number of other conditions like inflammation of the nose, mild or moderate ulcerative colitis and inflammatory skin conditions such as psoriasis and eczema.
Derminol Cream should be used with caution by people having high blood pressure, a family history of diabetes, osteoporosis, a family history of glaucoma, eye cataracts, stomach or duodenal ulcers, decreased liver or kidney function, mental health problems or those taking steroids. It should not be used by children and people who are allergic to it, had tuberculosis, any type of infection or a serious liver disease.
Derminol Cream is available to take as an inhaler device. It is also available as a nasal spray, cream and tablets or ointment. It can be taken once or twice daily, with or without food.
Some possible side effects include cramps, heavy bleeding, pain around the eyes and cheekbones, runny nose, tightness of the chest, body pain, congestion, difficulty with breathing, dryness or soreness of the throat, fever, hoarseness and voice changes.
Is It safe with alcohol?No interaction found
Are there any pregnancy warnings?Trim b 0.025% w/w/1% w/w cream may be unsafe to use during pregnancy.
Animal studies have shown adverse effects on the foetus, however, there are limited human studies. The benefits from use in pregnant women may be acceptable despite the risk. Please consult your doctor.
Are there any breast-feeding warnings?Unknown. Human and animal studies are not available. Please consult your doctor.
Is it safe to drive while on this medicine?There is no interaction between driving and consuming this drug. So dose alteration is not needed.
Does this affect kidney function?There is no data available. Please consult doctor before consuming the drug.
Does this affect liver function?There is no data available. Please consult doctor before consuming the drug.
The active constituent of this medication is a synthetic glucocorticoid that specifically binds to cytoplasmic receptors. This inhibits leukocyte entry at the inflammation site, interferes in inflammatory response mediator functioning, and reduces oedema and scar tissues.
Lybrate is a medium to provide our audience with the common information on medicines and does not guarantee its accuracy or exhaustiveness. Even if there is no mention of a warning for any drug or combination, it never means that we are claiming that the drug or combination is safe for consumption without any proper consultation with an expert.
Lybrate does not take responsibility for any aspect of medicines or treatments. If you have any doubts about your medication, we strongly recommend you to see a doctor immediately.